Limitations and Disclaimers1
Although PancraGEN is highly specific for malignancy, some malignant cysts may not be detected. There may also be individuals who are falsely identified as having a malignant cyst. Diagnosis and appropriate patient management are the responsibility of the referring physician or healthcare provider.
Reference 1. Al-Haddad MA, Kowalski T, Siddiqui A, et al. Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy. 2015;47(2):136-142.
Interpace Diagnostics is a registered trademark and business unit of Interpace Biosciences, Inc.™
©2022 Interpace Biosciences, Inc.™ All rights reserved.
Privacy Policy | HIPAA Privacy
This video consists of multiple chapters.
Click play to begin. Other video chapters can be selected by using the tools within the control bar.